AU2002329668A1 - Electroporative delivery of molecules to organs - Google Patents

Electroporative delivery of molecules to organs

Info

Publication number
AU2002329668A1
AU2002329668A1 AU2002329668A AU2002329668A AU2002329668A1 AU 2002329668 A1 AU2002329668 A1 AU 2002329668A1 AU 2002329668 A AU2002329668 A AU 2002329668A AU 2002329668 A AU2002329668 A AU 2002329668A AU 2002329668 A1 AU2002329668 A1 AU 2002329668A1
Authority
AU
Australia
Prior art keywords
organs
molecules
electroporative
delivery
electroporative delivery
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002329668A
Inventor
Erick Lawir Ayuni
Joseph Drabick
Jill Glasspool-Malone
Bartosz Kubisa
Robert W. Malone
Ralph Schmid
Aima Uduehi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU2002329668A1 publication Critical patent/AU2002329668A1/en
Abandoned legal-status Critical Current

Links

AU2002329668A 2001-08-07 2002-08-02 Electroporative delivery of molecules to organs Abandoned AU2002329668A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US60/310,239 2001-08-07

Publications (1)

Publication Number Publication Date
AU2002329668A1 true AU2002329668A1 (en) 2003-02-24

Family

ID=

Similar Documents

Publication Publication Date Title
AU2001280767A1 (en) Peptide-mediated delivery of molecules into cells
AUPR621501A0 (en) Delivery of ds rna
AU2002322719A1 (en) Delivery of therapeutic capable agents
AU2002341558A1 (en) Compositions and methods useful for non-invasive delivery of therapeutic molecules to the bloodstream
AU2002364893A1 (en) Delivery of medicaments to the nail
AU2002359659A1 (en) Cross reference to related application
AU2003292263A1 (en) Use of substituted 2-phenylbenzimidazoles as medicaments
AU2001232787A1 (en) Airway alkalinization as therapy for airway diseases
AU2002231206A1 (en) Treatment of depression
AUPR535101A0 (en) Novel therapeutic molecules
AU2002240942A1 (en) Improved delivery of benefit agents
WO2005033343A8 (en) Novel splice variants of human dkkl1
AU2002214868A1 (en) Therapeutic oligonucleotides of reduced toxicity
AU2003246614A1 (en) Novel use of lipopeptide preparations
AU2002327440A1 (en) Treatment of type i diabetes
AU2002953223A0 (en) Novel therapeutic molecules and uses thereof
AU2002329668A1 (en) Electroporative delivery of molecules to organs
AU2003255804A1 (en) Comparison of molecules using field points
AU2003290418A1 (en) Novel molecules to develop drug for the treatment of osteoporosis
AU2003205355A1 (en) Methods of administering gaultherin-containing compositions
AU6106801A (en) Trans-clitoral administration of therapy
AU2002213232A1 (en) Treatment of demyelinating diseases by administering gpe
AU2003208809A1 (en) Treatment of neuroblastoma
AU2001240017A1 (en) Human enzyme molecules
AU2003271712A1 (en) Treatment of amm